Lau WK - Search Results

1

Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H. Lau WK, et al. Urology. 2002 Apr;59(4):532-7. doi: 10.1016/s0090-4295(01)01589-8. Urology. 2002. PMID: 11927308

2

Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables.

Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Lau WK, et al. J Urol. 2002 Jan;167(1):117-22. J Urol. 2002. PMID: 11743287

3

Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Lau WK, et al. Mayo Clin Proc. 2000 Dec;75(12):1236-42. doi: 10.4065/75.12.1236. Mayo Clin Proc. 2000. PMID: 11126830

4

Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.

Lau WK, Blute ML, Bostwick DG, Weaver AL, Sebo TJ, Zincke H. Lau WK, et al. J Urol. 2001 Nov;166(5):1692-7. J Urol. 2001. PMID: 11586204

5

Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.

Lau WK, Zincke H, Lohse CM, Cheville JC, Weaver AL, Blute ML. Lau WK, et al. BJU Int. 2003 Jun;91(9):775-9. doi: 10.1046/j.1464-410x.2003.04237.x. BJU Int. 2003. PMID: 12780830

6

Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.

Zincke H, Lau W, Bergstralh E, Blute ML. Zincke H, et al. J Urol. 2001 Dec;166(6):2208-15. J Urol. 2001. PMID: 11696737

7

Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.

Chen K, Lee BL, Huang HH, Tan BY, Lee LS, Ng LG, Lau W, Yuen JS. Chen K, et al. Int J Urol. 2017 Jan;24(1):51-58. doi: 10.1111/iju.13237. Epub 2016 Oct 18. Int J Urol. 2017. PMID: 27757999

8

Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy.

Lu Y, Huang HH, Lau WKO. Lu Y, et al. World J Urol. 2020 Jan;38(1):103-109. doi: 10.1007/s00345-019-02752-4. Epub 2019 Apr 5. World J Urol. 2020. PMID: 30953141

9

Neutrophil-to-lymphocyte ratio independently predicts advanced pathological staging and poorer survival outcomes in testicular cancer.

Tan YG, Sia J, Huang HH, Lau WKO. Tan YG, et al. Investig Clin Urol. 2019 May;60(3):176-183. doi: 10.4111/icu.2019.60.3.176. Epub 2019 Apr 11. Investig Clin Urol. 2019. PMID: 31098425 Free PMC article.

10

High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.

Tan YG, Eu EWC, Huang HH, Lau WKO. Tan YG, et al. Int J Urol. 2018 Mar;25(3):232-238. doi: 10.1111/iju.13480. Epub 2017 Nov 1. Int J Urol. 2018. PMID: 29094397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters